RNA-seq gene expression and mass spectrometry–based proteomic data from the Cancer Cell Line Encyclopedia also showed a positive correlation between both vimentin gene and protein expression with CIS sensitivity across gastric and colon cancer cell lines (Supplemental Fig. S2, A and B), which complements our RPPA-based proteomic data. The gene discussed is VIM; the disease is malignant colon neoplasm.